Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalAmerican Journal of Hematology
Publication statusPublished - 3 Apr 2019
Externally publishedYes

Cite this